![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Research Papers
Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142.
Abstract
Arginine-rich sequences are found in many RNA-binding proteins and have been proposed to mediate specific RNA recognition. Fragments of the HIV-1 Tat protein that contain the arginine-rich region of Tat bind specifically to a 3-nucleotide bulge in TAR RNA. To determine the amino acid requirements for specific RNA recognition, we synthesized a series of mutant Tat peptides spanning this domain (YGRKKRRQRRRP) and measured their affinity and specificity for TAR RNA. Several corresponding mutations were introduced into the full-length Tat protein, and trans-activation activity was measured. Systematic substitution of arginine residues with alanines or lysines suggested that overall charge density is important but did not point to any specific residues as being essential for binding. A glutamine-to-alanine substitution had no effect on binding. Remarkably, peptides with scrambled or reversed sequences showed the same affinity and specificity for TAR RNA as the wild-type peptide. Trans-activation activity of the mutant Tat proteins correlated with RNA binding. Arginine-rich peptides from SIV Tat and from HIV-1 Rev, which can functionally substitute for the basic region of HIV-1 Tat, also bound specifically to TAR. Circular dichroism spectra suggest that the arginine-rich region of Tat is unstructured in the absence of RNA, becomes partially or fully structured upon binding, and induces a conformational change in the RNA. These results suggest that arginine-rich RNA-binding domains have considerable sequence flexibility, reminiscent of acidic domains found in transcriptional activators, and that RNA structure may provide much of the specificity for the interaction.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Xie, C. F. Invernizzi, S. Richard, and M. A. Wainberg Arginine Methylation of the Human Immunodeficiency Virus Type 1 Tat Protein by PRMT6 Negatively Affects Tat Interactions with both Cyclin T1 and the Tat Transactivation Region J. Virol., April 15, 2007; 81(8): 4226 - 4234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Berro, K. Kehn, C. de la Fuente, A. Pumfery, R. Adair, J. Wade, A. M. Colberg-Poley, J. Hiscott, and F. Kashanchi Acetylated Tat Regulates Human Immunodeficiency Virus Type 1 Splicing through Its Interaction with the Splicing Regulator p32. J. Virol., April 1, 2006; 80(7): 3189 - 3204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Jung and G. G. Brownlee A new promoter-binding site in the PB1 subunit of the influenza A virus polymerase. J. Gen. Virol., March 1, 2006; 87(Pt 3): 679 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Toth, P. Lischka, and T. Stamminger RNA-binding of the human cytomegalovirus transactivator protein UL69, mediated by arginine-rich motifs, is not required for nuclear export of unspliced RNA Nucleic Acids Res., February 25, 2006; 34(4): 1237 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. IWAZAKI, X. LI, and K. HARADA Evolvability of the mode of peptide binding by an RNA RNA, September 1, 2005; 11(9): 1364 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Olsen, T. E. Edwards, P. Deka, G. Varani, S. Th. Sigurdsson, and G. P. Drobny Monitoring tat peptide binding to TAR RNA by solid-state 31P-19F REDOR NMR Nucleic Acids Res., June 16, 2005; 33(11): 3447 - 3454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Petrillo, G. Rocheleau, B. Kelley-Clarke, and L. Gehrke Evaluation of the Conformational Switch Model for Alfalfa Mosaic Virus RNA Replication J. Virol., May 1, 2005; 79(9): 5743 - 5751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. BRADRICK and J. P. MARINO Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA RNA, September 1, 2004; 10(9): 1459 - 1468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Rocheleau, J. Petrillo, L. Guogas, and L. Gehrke Degenerate In Vitro Genetic Selection Reveals Mutations That Diminish Alfalfa Mosaic Virus RNA Replication without Affecting Coat Protein Binding J. Virol., August 1, 2004; 78(15): 8036 - 8046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. LAFOREST and L. GEHRKE Spatial determinants of the alfalfa mosaic virus coat protein binding site RNA, January 1, 2004; 10(1): 48 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. SAUNDERS and G. N. BARBER The dsRNA binding protein family: critical roles, diverse cellular functions FASEB J, June 1, 2003; 17(9): 961 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Xie, M. A. Wainberg, and A. D. Frankel Replication of Human Immunodeficiency Viruses Engineered with Heterologous Tat-Transactivation Response Element Interactions J. Virol., February 1, 2003; 77(3): 1984 - 1991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Bres, R. Kiernan, S. Emiliani, and M. Benkirane Tat Acetyl-acceptor Lysines Are Important for Human Immunodeficiency Virus Type-1 Replication J. Biol. Chem., June 14, 2002; 277(25): 22215 - 22221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. P. Torchilin, R. Rammohan, V. Weissig, and T. S. Levchenko TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors PNAS, June 28, 2001; (2001) 151247498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-S. Nam, A. Petrovic, K.-S. Jeong, and S. Venkatesan Exchange of the Basic Domain of Human Immunodeficiency Virus Type 1 Rev for a Polyarginine Stretch Expands the RNA Binding Specificity, and a Minimal Arginine Cluster Is Required for Optimal RRE RNA Binding Affinity, Nuclear Accumulation, and trans-Activation J. Virol., March 15, 2001; 75(6): 2957 - 2971. [Abstract] [Full Text]
|
|
|
|
 |
|
 Z. Dominski, J. A. Erkmann, J. A. Greenland, and W. F. Marzluff Mutations in the RNA Binding Domain of Stem-Loop Binding Protein Define Separable Requirements for RNA Binding and for Histone Pre-mRNA Processing Mol. Cell. Biol., March 15, 2001; 21(6): 2008 - 2017. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Ho, S. R. Schwarze, S. J. Mermelstein, G. Waksman, and S. F. Dowdy Synthetic Protein Transduction Domains: Enhanced Transduction Potential in Vitro and in Vivo Cancer Res., January 1, 2001; 61(2): 474 - 477. [Abstract] [Full Text]
|
|
|
|
|
|
K.-T. Jeang, H. Xiao, and E. A. Rich Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat J. Biol. Chem., October 8, 1999; 274(41): 28837 - 28840. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Ansari, M. Safak, G. L. Gallia, B. E. Sawaya, S. Amini, and K. Khalili Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity J. Gen. Virol., October 1, 1999; 80(10): 2629 - 2638. [Abstract] [Full Text]
|
|
|
|
|
|
M.-S. Tsai, Y.-H. Hsu, and N.-S. Lin Bamboo Mosaic Potexvirus Satellite RNA (satBaMV RNA)-Encoded P20 Protein Preferentially Binds to satBaMV RNA J. Virol., April 1, 1999; 73(4): 3032 - 3039. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. Ippolito and T. A. Steitz A 1.3-A resolution crystal structure of the HIV-1 trans-activation response region RNA stem reveals a metal ion-dependent bulge conformation PNAS, August 18, 1998; 95(17): 9819 - 9824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tan and A. D. Frankel A novel glutamine-RNA interaction identified by screening libraries in mammalian cells PNAS, April 14, 1998; 95(8): 4247 - 4252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Harada, S. S. Martin, R. Tan, and A. D. Frankel Molding a peptide into an RNA site by in vivo peptide evolution PNAS, October 28, 1997; 94(22): 11887 - 11892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ambrosino, M. R. Ruocco, X. Chen, M. Mallardo, F. Baudi, S. Trematerra, I. Quinto, S. Venuta, and G. Scala HIV-1 Tat Induces the Expression of the Interleukin-6 (IL6) Gene by Binding to the IL6 Leader RNA and by Interacting with CAAT Enhancer-binding Protein beta (NF-IL6) Transcription Factors J. Biol. Chem., June 6, 1997; 272(23): 14883 - 14892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rusnati, D. Coltrini, P. Oreste, G. Zoppetti, A. Albini, D. Noonan, F. d'A. di Fagagna, M. Giacca, and M. Presta Interaction of HIV-1 Tat Protein with Heparin. ROLE OF THE BACKBONE STRUCTURE, SULFATION, AND SIZE J. Biol. Chem., April 25, 1997; 272(17): 11313 - 11320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Hamy, E. R. Felder, G. Heizmann, J. Lazdins, F. Aboul-ela, G. Varani, J. Karn, and T. Klimkait An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication PNAS, April 15, 1997; 94(8): 3548 - 3553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Mori, H. Matsubara, S. Murasawa, K. Kijima, K. Maruyama, H. Tsukaguchi, N. Okubo, T. Hamakubo, T. Inagami, T. Iwasaka, et al. Translational Regulation of Angiotensin II Type 1A Receptor: Role of Upstream AUG Triplets Hypertension, November 1, 1996; 28(5): 810 - 817. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Burd and G Dreyfuss Conserved structures and diversity of functions of RNA-binding proteins Science, July 29, 1994; 265(5172): 615 - 621. [Abstract] [PDF]
|
|
|
|
|
|
D Willbold, R Rosin-Arbesfeld, H Sticht, R Frank, and P Rosch Structure of the equine infectious anemia virus Tat protein Science, June 10, 1994; 264(5165): 1584 - 1587. [Abstract] [PDF]
|
|
|
|
|
|
J. Puglisi, R Tan, B. Calnan, A. Frankel, and Williamson JR Conformation of the TAR RNA-arginine complex by NMR spectroscopy Science, July 3, 1992; 257(5066): 76 - 80. [Abstract] [PDF]
|
|
|
|
 |
|
 C D Southgate and M R Green The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes & Dev., December 1, 1991; 5(12b): 2496 - 2507. [Abstract] [PDF]
|
|
|
|
|
|
F Wu, J Garcia, D Sigman, and R Gaynor tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. Genes & Dev., November 1, 1991; 5(11): 2128 - 2140. [Abstract] [PDF]
|
|
|
|
|
|
A. Friedler, D. Friedler, N. W. Luedtke, Y. Tor, A. Loyter, and C. Gilon Development of a Functional Backbone Cyclic Mimetic of the HIV-1 Tat Arginine-rich Motif J. Biol. Chem., July 28, 2000; 275(31): 23783 - 23789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Torchilin, R. Rammohan, V. Weissig, and T. S. Levchenko TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors PNAS, July 17, 2001; 98(15): 8786 - 8791. [Abstract] [Full Text] [PDF]
|
|
